DCGI approves Themis Medicare’s Viralex as COVID-19 treatment
The drug is also effective for viruses causing viral respiratory infections
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
DCGI approval
GSK launches once daily, Single Inhaler-Triple Therapy for COPD patients
The launch follows the product’s approval by the Drugs Controller General of India (DCGI) for use of Trelegy Ellipta as…
DCGI approves Glenmark’s phase-I clinical trial for its novel molecule GRC 54276
The company will initiate the trial by June 2022 to determine the safety, tolerability and preliminary anti-tumour activity of the…
Serum Institute seeks EUA for TB vaccine
The EUA application was submitted on 22nd March by Prakash Kumar Singh, Director, Government and Regulatory Affairs, SII
Novavax’s COVID-19 vaccine gets DCGI approval for teens
The authorisation is a global first for the age group for the vaccine, which is manufactured and marketed by the Serum Institute…
AstraZeneca Pharma India gets DCGI approval for Osimertinib tablets
It is now approved as monotherapy for adjuvant treatment after complete tumour resection in patients with NSCLC
Centaur Pharma to launch WOXHeal, diabetic foot ulcer drug
It is a topical solution that will cost Rs 1850 for a week’s treatment, and can reportedly help prevent amputation
Zenara Pharma, a Biophore subsidiary, gets DCGI nod for favipiravir tablets
The company informed that these tablets, to be marketed under brand name Favizen, will be manufactured with in-house API
Mylan receives DCGI approval in India for TB drug, Pretomanid
Pretomanid is only the third new anti-tuberculosis (TB) drug developed specifically for drug-resistant forms of the disease to be…
Biocon presents key Insights into clinical study that enabled DCGI approval of Itolizumab
A multi-centric, open label, two-arm randomized pivotal clinical trial was conducted in 30 eligible patients at four hospitals…